A Randomized, Open-label, Multiple-dose, Parallel Study to Investigate The Effect of Cilostazol on the Disposition of Simvastatin in Healthy Male Volunteers
Sponsor study identifier
interventional
20
1 country
1
Study Start
April 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedThis is a randomized, open-label, single \& multiple-dose, parallel study to investigate the effect of cilostazol on the disposition of simvastatin \& pravastatin in healthy male volunteers
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2015
Date type not reportedThis date has not been verified as actual or estimated.
April 23, 2015
Actual (reported)April 30, 2015
Actual (reported)August 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
AUC (area under the time-concentration curve) of Simvastatin
up to 12 hours after Simvastatin dosing
Cmax (maximum plasma concentration) of Simvastatin
up to 12 hours after Simvastatin dosing
Cmax (maximum plasma concentration) of Pravastatin
up to 12 hours after Pravastatin dosing
AUC (area under the time-concentration curve) of Pravastatin
up to 12 hours after Pravastatin dosing
Simvastatin 40 mg on Day 1. Cilostazol 100 mg twice a day for 6 days. Simvastatin 40 mg and Cilostazol 100 mg twice a day on Day 8.
Pravastatin 20 mg on Day 1. Cilostazol 100 mg twice a day for 6 days. Pravastatin 20 mg and Cilostazol 100 mg twice a day on Day 8.
Simvastatin 40 mg on Day 1 \& Day 8.
Pravastatin 20 mg on Day 1 \& Day 8.
Ajou University Medical Center
Suwon, Gyeonggi-do, 443-380, South Korea
Doo-Yeoun Cho, MD
Ajou University School of Medicine
First Submitted
April 23, 2015
First Posted
April 30, 2015
Study Start
April 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2015
Estimated (date passed)A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
Cilostazol 100 mg twice a day for 6 days \& on Day 8 with statin.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 1, 2015
Record last verified: 2015-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: